Eye test (VEP) improves optic neuritis diagnosis

Credibility

Interest

Key Takeaway

Adding Visual Evoked Potentials (VEPs) to current optic neuritis checks makes it easier to spot cases early and improves diagnostic confidence.

What They Found

Researchers looked at 71 people who had new eye symptoms and tested them with MRI, OCT (a camera-like scan of the eye), and VEPs (a test that measures how the brain responds to visual signals). VEPs correctly identified optic neuritis most of the time, with an overall accuracy near 89% — think of it like a reliable smoke detector for this eye problem. When VEPs were added to the existing ICON 2022 rules, the tests caught all true cases in this group (100% sensitivity), meaning fewer missed diagnoses. Adding VEPs also kept the same rate of false alarms (same specificity) but improved the chance a positive test really meant disease (positive predictive value). Overall, combining VEPs with the standard rules made the diagnosis more accurate (about 92%).

Who Should Care and Why

People with suspected optic neuritis — sudden vision blurring, eye pain, or color changes — should care because VEPs could help doctors confirm the problem faster, like getting a second opinion from a different tool. Caregivers can benefit because clearer diagnosis may speed up treatment decisions and reduce worry, similar to using both a thermometer and a pulse check to understand an illness. Neurologists and eye doctors might use VEPs as an extra test when MRI or eye scans are unclear, offering another piece of evidence. MS patients should note optic neuritis can be linked to MS, so better tests help guide monitoring or treatment plans. In daily life, a more certain diagnosis may mean quicker treatment, which can improve recovery and reduce uncertainty for patients and families.

Important Considerations

This study looked at a relatively small group (71 people) from one setting, so results might not be identical everywhere or in larger groups. VEPs can be affected by other eye problems (like a cataract) or by how tests are done, so an abnormal VEP doesn’t always mean optic neuritis by itself. Doctors will still use VEPs together with MRI, eye scans, and symptoms — no single test replaces a full clinical evaluation.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Specific Symptoms Clinical Trials

Article Topics:

MRIOptic neuritisdiagnostic criteriaoptical coherence tomographyvisual evoked potentials

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News